Pura Vida Investments’s AbbVie ABBV Stock Holding History

Pura Vida Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-65,800	Closed	-$7.41M	–	275
2021 Q2	$7.41M	Buy	+65,800	New	+$7.41M	0.23%	91

Other funds holding ABBV

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pura Vida Investments's ABBV Position: Q4 2022 in Review

Pura Vida Investments sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 50,000 shares — an estimated $6.71M sold.

Pura Vida Investments first reported a position in ABBV in Q2 2015 and held it in 10 quarters. The position peaked at $9.42M in Q4 2016. 3,170 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Pura Vida Investments reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 50,000 AbbVie shares in Q4 2022, an estimated $6.71M.
Pura Vida Investments first reported a position in AbbVie in Q2 2015 and held it in 10 quarters.
Pura Vida Investments's AbbVie position peaked at $9.42M in Q4 2016.
3,170 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.